Package 43598-859-11

{"route": ["INTRAVENOUS"], "spl_id": "72a1e18f-9377-5bc3-4638-32d7212872b6", "openfda": {"upc": ["0343598859118"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["f34c931c-78b9-90c1-3fa5-bb34a227f2ad"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc.,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (43598-859-11)  / 1 mL in 1 VIAL", "package_ndc": "43598-859-11", "marketing_start_date": "20190906"}], "brand_name": "Fosaprepitant", "product_id": "43598-859_72a1e18f-9377-5bc3-4638-32d7212872b6", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "43598-859", "generic_name": "Fosaprepitant", "labeler_name": "Dr. Reddy's Laboratories Inc.,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA209965", "marketing_category": "ANDA", "marketing_start_date": "20190906", "listing_expiration_date": "20261231"}